Vida Ventures Advisors, LLC
- SEC CIK
- 0001831423
- Latest filing
- Nov 3, 2025
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed Apr 3, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 3
- −3 vs. Q4 2024
- Portfolio value
- $13.6M
- −$132.7M (−90.7%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| KYTXKyverna Therapeutics, Inc. | COM | 4,523,924 | $8.73M | 64.0% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,798,163 | $2.63M | 19.3% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 2,765,314 | $2.28M | 16.7% | 00.0% | Unchanged | History |
Sold out since Q4 2024 (3)
Positions held at the end of Q4 2024 that are gone from this filing.
| Security | Class | Shares in Q4 2024 | Value in Q4 2024 | % of portfolio in Q4 2024 | History |
|---|---|---|---|---|---|
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,931,818 | $65.9M | 45.0% | History |
| TECXTectonic Therapeutic, Inc. | COM | 1,028,674 | $47.5M | 32.5% | History |
| DYNDyne Therapeutics, Inc. | COM | 407,499 | $9.60M | 6.6% | History |